Investing.com - EDAP reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
EDAP announced earnings per share of €0.04 on revenue of €13.97M. Analysts polled by Investing.com anticipated EPS of €0.0063 on revenue of €13.23M.
EDAP shares are up 20.2% from the beginning of the year and are trading at €7.200 , down-from-52-week-high.They are outperforming the Nasdaq which is down 7.69% from the start of the year.
EDAP follows other major Healthcare sector earnings this month
EDAP's report follows an earnings missed by Merck ADR on Thursday, March 3, 2022, who reported EPS of €0.4558 on revenue of €5.77B, compared to forecasts EPS of €0.4818 on revenue of €5.88B.
BioNTech had beat expectations on Wednesday with first quarter EPS of €12.18 on revenue of €5.53B, compared to forecast for EPS of €7.44 on revenue of €3.92B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar